Frequent β-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential

American Journal of Clinical Pathology

Volumn 129, Issue 3, 2008, Pages 416-423

  Wu, Julie M ^a   Montgomery, Elizabeth A ^a   Iacobuzio Donahue, Christine A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Colorectal; Hyperplastic polyps; Serrated adenoma; Wnt pathway

Indexed keywords

BETA CATENIN; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 53; CYTOKERATIN 7; PROTEIN P53; CDX2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOMA; ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE POLYP; MALE; PRIORITY JOURNAL; SESSILE SERRATED ADENOMA; STATISTICAL SIGNIFICANCE; CELL NUCLEUS; COLON POLYP; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER;

ADENOMA; BETA CATENIN; CELL NUCLEUS; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 41649102270     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/603UQKM7C2KELGJU     Document Type: Article

References (30)

1. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology. 2000;37:295-301.
2. Jass JR, Iino H, Ruszkiewicz A, et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 2000;47:43-49.
3. Torlakovic E, Skovlund E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81.
4. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778-796.
5. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878-4881.
6. Sawyer EJ, Cerar A, Hanby AM, et al. Molecular characteristics of serrated adenomas of the colorectum. Gut. 2002;51:200-206.
7. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131:1400-1407.
8. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144.
9. O'Brien MJ, Yang S, Clebanoff JL, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423-434.
10. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001;93:1307-1313.
11. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
12. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act." Am J Clin Pathol. 2006;126:564-571.
13. Tatsumi N, Mukaisho K, Mitsufuji S, et al. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases. Dig Dis Sci. 2005;50:1741-1746.
14. McGregor DK, Wu TT, Rashid A, et al. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol. 2004;28:712-718.
15. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol. 2001;159:2239-2248.
16. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469-480.
17. Zhang PJ, Shah M, Spiegel GW, et al. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl Immunohistochem Mol Morphol. 2003;11:306-310.
18. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32-40.
19. Chlumska A, Boudova L, Zamecnik M. Sessile serrated adenomas of the large bowel: clinicopathologic and immunohistochemical study including comparison with common hyperplastic polyps and adenomas. Cesk Patol. 2006;42:133-138.
20. Rex DK, Smith JJ, Ulbright TM, et al. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology. 1992;102:317-319.
21. Yamamoto T, Konishi K, Yamochi T, et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. Br J Cancer. 2003;89:152-157.
22. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275:1787-1790.
23. Mirabelli-Primdahl L, Gryfe R, Kim H, et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 1999;59:3346-3351.
24. Shitoh K, Furukawa T, Kojima M, et al. Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability. Genes Chromosomes Cancer. 2001;30:32-37.
25. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324-331.
26. Mariadason JM, Bordonaro M, Aslam F, et al. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res. 2001;61:3465-3471.
27. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379-383.
28. Escaffit F, Paré F, Gauthier R, et al. Cdx2 modulates proliferation in normal human intestinal epithelial crypt cells. Biochem Biophys Res Commun. 2006;342:66-72.
29. Blache P, van de Wetering M, Duluc I, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004;166:37-47.
30. Biemer-Huttmann AE, Walsh MD, McGuckin MA, et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res. 2000;6:1909-1916.